Aberdeen Group’s Affimed AFMD Stock Holding History

Aberdeen Group’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,862	Closed	-$15.1K	–	952
2025 Q1	$15.1K	Hold	20,862	–	–	﹤0.01%	941
2024 Q4	$24.8K	Hold	20,862	–	–	﹤0.01%	930
2024 Q3	$70.1K	Hold	20,862	–	–	﹤0.01%	914
2024 Q2	$114K	Hold	20,862	–	–	﹤0.01%	940
2024 Q1	$111K	Hold	20,862	–	–	﹤0.01%	941
2023 Q4	$130K	Buy	+20,862	New	+$86.6K	﹤0.01%	954

Other funds holding AFMD

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aberdeen Group's AFMD Position: Q2 2025 in Review

Aberdeen Group sold out of Affimed (AFMD) in Q2 2025, closing a stake of 20,862 shares — an estimated $15.1K sold.

Aberdeen Group first reported a position in AFMD in Q4 2023 and held it in 6 quarters. The position peaked at $130K in Q4 2023. 3 funds tracked by Wall St. Rank hold AFMD as of Q2 2025.

Aberdeen Group reported no remaining Affimed position as of Q2 2025 after selling out during the quarter.
Aberdeen Group sold 20,862 Affimed shares in Q2 2025, an estimated $15.1K.
Aberdeen Group first reported a position in Affimed in Q4 2023 and held it in 6 quarters.
Aberdeen Group's Affimed position peaked at $130K in Q4 2023.
3 funds tracked by Wall St. Rank held Affimed as of Q2 2025.

Based on Aberdeen Group's 13F filing for Q2 2025, filed 24 Jul 2025.